Dr. Nimer has been studying the transcriptional regulation of normal and malignant hematopoiesis for decades, with the aim of understanding how the normal processes of stem cell self-renewal and differentiation are regulated and how these processes are aberrant in the myeloid malignancies. Overall, his lab has focused on defining genes that contribute to the development and progression of myelodys… Read more ›
| University | Degree | Focus | Graduated |
|---|---|---|---|
| University of Chicago Pritzer School of Medicine | Doctorate | Other | 1979 |
| Institution | Focus | Year |
|---|---|---|
| Residency - UCLA Center for Health Sciences | Internal Medicine | 1982 |
| Fellowship - UCLA - David Geffen School of Medicine | Hematology/Oncology | 1986 |
| Certification | Cert. Body | Year |
|---|---|---|
| Internal medicine Sub-Specialty: Medical Oncology | Internal Medicine | Not Specified |
| Internal medicine | Internal Medicine | 1982 |
| Internal medicine Sub-Specialty: Medical Oncology | Internal Medicine | 1985 |
| Internal medicine | Internal Medicine | 1986 |
Years In Practice: 39 (started in 1986)
Accepts New Patients: No
Stephen David Nimer, MD has not yet listed the medications that he commonly prescribes.
Stephen David Nimer, MD has not yet specified the insurance plans he accepts.
